BCA Advanced Therapies Network

Innovation Partner

BCA centers generate over $3B in revenue annually managing over 50% of the country’s supply of blood and blood components from over 500 facilities owned by 65 centers in 43 states supplying biomaterials from over 3.5 million annual donors to thousands of hospitals. For advanced therapies, BCA sites annually perform over 10,000 cell therapy (autologous & healthy donor) collections and over 20,000 therapeutic apheresis procedures on 400 Optia devices at over 60 locations. Many of these sites also have cryopreservation capabilities.